Back to top anchor

A head-to-head trial of cytisine and varenicline for smoking cessation

Year:
2016
Duration:
47 months
Approved budget:
$1,599,944.84
Researchers:
Associate Professor Natalie Walker
Health issue:
Addiction (alcohol/drugs/gambling/smoking)
Proposal type:
Project
Lay summary
Cytisine, a natural product, found in plants such as the Golden Rain and New Zealand Kowhai, partially blocks the effects of nicotine on the brain. Cytisine has been used as a smoking cessation treatment in several Central and Eastern European countries since the 1960s, is inexpensive compared to other cessation medications and has few known side effects. New Zealand research has shown cytisine to be more effective than nicotine replacement therapy at helping people quit smoking. Using a clinical trial design we plan to investigate whether cytisine is as good as varenicline (the most effective, but most expensive, smoking cessation medication currently available in New Zealand) for helping people quit smoking.